临床前体内影像市场报告：2031 年趋势、预测与竞争分析

全球临床前体内影像市场前景光明，在研发和药物发现市场中充满机会。预计到 2031 年，全球临床前体内影像市场规模将达到 15 亿美元，2025 年至 2031 年的复合年增长率为 6.2%。该市场的主要驱动因素是慢性病盛行率的上升、对非侵入性小动物成像技术的需求的不断增长，以及对临床前研究活动的资金增加。

• 在模态类别中，Lucintel 预测超音波系统部分将在预测期内经历最高的成长。
• 从应用角度来看，由于研究和药物开发中越来越多地采用这种模式，研究和开发将继续成为最大的部分。
• 按地区划分，由于临床前研究数量的增加以及加拿大政府对研究和创新的津贴增加，预计北美仍将是最大的地区。

临床前体内影像市场的策略性成长机会

临床前体内成像领域的特点是跨各种应用的策略性成长机会。由于技术创新和研究活动的不断增加，成长潜力仍在持续。

• 扩展成像模式：多模态系统的获取为推进临床前研究提供了途径。此策略将有助于详细研究复杂的细胞现象和疾病病理，为治疗方法发展开闢新的途径。
• 成像过程中成像系统的人工智慧开发：影像分析的另一个具有高成长机会的部分是人工智慧影像分析，它增强了影像资料的使用率。多项研究表明，人工智慧在影像处理中的应用有助于改善监测方法，并最终提高对疾病过程和治疗反应的理解。
• 开发具有成本效益的成像解决方案：建构具有成本效益的成像解决方案可满足对低成本、易于使用的成像技术的需求，尤其是在临床前研究中。更便宜、更易于存取的系统可能会提高研究能力并使更多机构能够进行研究。
• 可携式成像技术的发展：可携式成像技术的发明透过其灵活性和可用性扩展了研究的可能性。这个可携式系统可以在小型实验室和现场工作等各个层面进行体内成像，扩大了临床前研究的范围。
• 即时成像的创新：即时成像可以持续评估动态生物过程，开闢新方法并实现进一步发展。这将使我们更容易追踪细胞功能和疾病的研究进展，从而加强研究和治疗方法。

由于通用、可访问性和技术丰富性的原则，这些成长机会为临床前体内成像发展提供了巨大的潜力。解决这些问题将有助于推进和改进您的研究。

临床前体内影像市场驱动因素与挑战

临床前体内影像市场受到多种因素的影响，包括技术、经济状况和监管因素。人们需要了解一些因素，包括帮助市场导航和帮助成长。

推动临床前体内影像市场发展的因素有：

• 技术进步：成像系统的技术发展，包括即时和多模态成像技术，正在促进临床前体内成像的扩展。这些变化将提高成像工具的功能、精度和能力，从而实现更深入的研究。
• 对高解析度成像的需求不断增加：值得注意的是，用于探索病原体引起的复杂生物过程和相互作用的高分辨率成像的增长仍然是一个主要驱动力。因此，临床前测试不再局限于简单的成像技术，而是提供更深入见解的更先进的成像技术。
• 开发具有成本效益的解决方案：开发经济实惠的成像解决方案有助于增加这些技术的采用并推动市场成长。价格实惠的成像设备的出现使得在各种环境下（包括资源受限的环境下）采用和推进研究变得更加容易。
• 监管和合规要求：监管问题和安全指南对于市场的成长至关重要。只有符合必要监管标准的成像技术才允许上市，从而提高安全性和效率。

临床前体内影像市场面临哪些挑战？

• 竞争市场动态：临床前体内影像市场本质上竞争非常激烈。此外，公司需要创新并重新定位其产品在市场上以保持相关性并满足研究需求。
• 先进技术高成本：大多数先进成像技术往往成本高昂，限制了其广泛应用，尤其是在较小的研究机构和资源有限的地区。这些成本可能会影响新成像系统的采用和利用。
• 技术复杂性和整合问题：先进影像处理系统的技术复杂性和整合新组件所面临的不可预见的挑战很可能决定此类系统在该领域的成功。这意味着技术和操作都必须足够直观，以免妨碍现场的成功部署和性能。

这些市场驱动因素和挑战如何与临床前体内影像市场相互作用？成长由技术发展和需求推动，但市场范围受到成本、法规和市场竞争的限制。成功克服这些挑战并同时利用驱动力实现预期的工业成果至关重要。

目录

第一章执行摘要

第二章全球临床前体内影像市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章 2019年至2031年市场趋势及预测分析

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球临床前体内影像市场趋势（2019-2024）及预测（2025-2031）
• 全球临床前体内影像市场（按类型）
  • 光学成像
  • 核子造影
  • MRI显影剂
  • 超音波显影剂
  • CT显影剂
• 全球临床前体内影像市场（按方式）
  • 光学成像系统
  • 临床前核子造影系统
  • 微型磁振造影系统
  • 微型超音波系统
  • 微型CT系统
  • 临床前光声成像系统
  • 临床前磁粒子成像（MPI）系统
• 全球临床前体内影像市场（按应用）
  • 研究与开发
  • 药物研发
• 全球临床前体内影像市场（按通路）
  • 製药公司
  • 生技公司
  • 研究所
  • 其他的

第四章2019年至2031年区域市场趋势与预测分析

• 区域临床前体内影像市场
• 北美临床前体内影像市场
• 欧洲临床前体内影像市场
• 亚太临床前体内影像市场
• 世界其他地区临床前体内影像市场

第五章 竞争分析

• 产品系列分析
• 业务整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球临床前体内影像市场的成长机会（按类型）
  • 全球临床前体内影像市场中不同模式的成长机会
  • 全球临床前体内影像市场的成长机会（按应用）
  • 全球临床前体内成像市场通路的成长机会
  • 区域临床前体内影像市场的成长机会
• 全球临床前体内影像市场的新趋势
• 战略分析
  • 新产品开发
  • 全球临床前体内影像市场容量不断扩大
  • 全球临床前体内影像市场的合併、收购与合资企业
  • 认证和许可

第七章主要企业简介

• Bruker Corporation
• Siemens
• TriFoil Imaging
• PerkinElmer
• VisualSonics

The future of the global preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets. The global preclinical in-vivo imaging market is expected to reach an estimated $1.5 billion by 2031 with a CAGR of 6.2% from 2025 to 2031. The major drivers for this market are the growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.

• Lucintel forecasts that, within the modality category, micro-ultrasound systems segment is expected to witness the highest growth over the forecast period.
• Within the application category, research & development will remain the largest segment due to the increased adoption of modalities for research and drug development.
• In terms of region, North America will remain the largest region due to the increasing volume of preclinical research and growing government funding for research and innovation in Canada.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Preclinical In-Vivo Imaging Market

The sphere of preclinical in-vivo imaging is advancing with a few emerging trends that are overhauling the research and the development activities. The preclinical in-vivo imaging process is characterized by the inclusion of novel technologies or techniques which improve the modalities used.

• Integration of Multimodal Imaging: Interventional and multimodal imaging has led to an increasing trend in imaging systems where PET, MRI and CT techniques are integrated together. Such systems enhance the knowledge regarding the regularity of biological processes, and elucidate pathways that are likely to be disrupted in disease states due to the ability to capture anatomic, functional and molecular processes concurrently.
• Advancement in Contrast Agents and Probes: There is an improved efficiency of in-vivo imaging procedures because of new imaging agents and new types of imaging probes. Preclinical target evaluation and diagnostics may benefit from such innovations because they enable the assessment of the disease process and the efficacy of therapeutic agents on a cellular and molecular level more so than previously possible.
• Utilization of Artificial Intelligence: There has been an increasing adoption of systems that use images and incorporate the application of attention AI that is used for imaging enhancement and interpretation of results. Big data from imaging studies can be analyzed by the machine and produce statistically significant biomarkers where human intelligence is limited significantly improving the quality and pace of research.
• Emergence of Portable Imaging Systems: The portable and compact imaging modalities are maturing and are being utilized in preclinical investigations. Such systems are versatile and allow the possibility of in-vivo imaging in conventional laboratories or field settings without degrading the quality of imaging.
• Advances in Real-Time Imaging: Continuous imaging techniques enhance the prospects of real-time monitoring of biological processes as they occur as opposed to destructive sampling methods. New imaging modalities especially optical and fluorescence have breached the barriers of resolution and temporal limitations to allow time-lapse imaging of cellular events and processes, thus unveiling disease pathology and therapeutic strategies.

These trends are driving significant progress in preclinical in-vivo imaging by praising the level of analysis, facilitating the acquisition of imagery, and getting more work done in quicker times. They are changing the processes by which diseases are studied and new remedies are created by the investigators.

Recent Developments in the Preclinical In-Vivo Imaging Market

There is ever increasing transformation in research capabilities and understanding of biological processes through the recent developments in preclinical in-vivo imaging. Employment of various technologies and improvement of existing methodologies that make research accurate, targeting and within shorter periods are important features of, recent technology advancement.

• Enhanced Multimodal Imaging Systems: Today's multimodal imaging systems involve the combination of previously disparate imaging techniques such as PET, MRI, and CT. This facilitates a multi-faceted approach to the study of biological processes and the acquisition of anatomical, functional and molecular information that will help to resolve some of the challenges posed by preclinical research.
• Advanced Contrast Agents and Probes: The latest imaging contrast agents and imaging probes are increasing the efficacy of in-vivo imaging. These developments allow researchers to demonstrate better targeting of, and distinguish between, various cellular and molecular species, thus improving the study of disease mechanisms and treatment efficiency.
• AI-Driven Image Analysis: The application of artificial intelligence (AI) specifically in image analysis is one of the notable aspects of development. AI algorithms assist in the acquisition and analysis of a large amount of imaging data, allowing gaining of high precision information and expanding the effectiveness to research diagnosis.
• Development of Portable Imaging Technologies: In recent years, there has been a remarkable progress in the use of non-invasive imaging technologies. These systems are efficient due to their flexibility for application in both smaller research laboratories and in the field, thus enhancing the advanced imaging and flexibility to the diverse needs of research.
• Recent Developments in Real-Time Imaging: Here are developments in real-time imaging techniques like highly-resolution optical imaging and fluorescence imaging that aid to continuous observation of biological activities. These techniques give a dynamic view of cellular processes and development of disease, thereby improving the understanding of treatment outcomes and disease processes.

These developments are advancing the field of preclinical in-vivo imaging by technology improvement, enhancing accessibility and expanding research efforts. New tools and methodologies being adopted are facilitating advancement in the understanding of biological systems and the creation of new therapies.

Strategic Growth Opportunities for Preclinical In-Vivo Imaging Market

The sector of preclinical in-vivo imaging is characterized by presence of several strategic growth opportunities in various applications. Growth potentials are persist because of technology innovations and increasing research activity.

• Extension of Modalities for Imaging: The acquisition of multimodal one systems present an avenue of advancing preclinical studies since improving these imaging techniques incorporate more than one. This strategy enhances an in-depth investigation of complicated cellular events and disease pathology, thus offering new avenues in therapy development.
• Development of AI for Imaging System in Imaging Process: Another area of imaging analysis which has a high growth opportunity is AI Imaging Analysis wherein the uses of imaging data are enhanced. Various studies show how AI application on imaging will help improve research processes and even enhance the understanding of disease processes and responses to treatment.
• Development of Cost-Effective Imaging Solutions: The creation of cost-effective imaging solutions meets the demand for imaging technologies that are both low-cost and easy to use, especially in preclinical research. Less expensive systems and greater availability may increase the capacity of research and allow for research to be conducted in a greater number of institutions.
• Growth in Portable Imaging Technologies: The invention of portable imaging technologies extends the possibilities of research through its flexibility and availability. Portable systems permit the performance of in-vivo imaging at various levels such as small labs and fieldwork thus broadening the preclinical scope of investigations.
• Innovations in Real-Time Imaging: Real-time imaging does develop new ways by continuous asses of dynamic biological processes it allows further growth. This makes it easy to track cellular functions and developments in diseases and thus enhance research and therapy methods.

These growth opportunities present amazing potential for the development of preclinical in-vivo imaging in recall of the principles of commonality and, the accessibility and which are richer in technology. Addressing these areas will help in attaining progress and improvement of research.

Preclinical In-Vivo Imaging Market Driver and Challenges

The factors affecting the preclinical in-vivo imaging market are quite a number, technological factors, economic conditions and regulations among others. There are elements which a person should know and they include assistance in the market navigation as well as help in growth.

The factors responsible for driving the preclinical in-vivo imaging market include:

• Technological Advancements: Growth of technologies in regards to the imaging systems such as real time and multimodal imaging technologies is promoting expansion of the preclinical in-vivo imaging. These changes enhance imaging tools' ability, precision, and potential to create research that is more detailed.
• Increasing Demand for High-Resolution Imaging: It is important to note that the growth in high-resolution imaging, used to explore the activities of complex biological processes and pathogen-induced interactions, remains the major factor. Therefore, no more preclinical studies are performed with simple imaging techniques, but with advanced imaging technologies providing deeper insights.
• Development of Cost-Effective Solutions: The development of affordable imaging solutions is a factor spurring growth of the market by expanding the reach of such technologies. The availability of inexpensive imaging equipment makes it easier to incorporate and promote research in all settings including those with resource constraints.
• Regulatory and Compliance Requirements: Regulatory concerns and safety guidelines are crucial for the growth of the market. Only those imaging technologies that meet the necessary regulatory standards are distributed into the market to enhance safety and efficiency, both critical for large-scale use.

Challenges in the preclinical in-vivo imaging market are:

• Competitive Market Dynamics: It is the nature of the market for preclinical in-vivo imaging that makes it worse as it is a very competitive one. Moreover, there is a need for companies to innovate and reposition their products in the market to remain relevant and meet research demands.
• High Costs of Advanced Technologies: Most of these advanced imaging technologies tend to be cost prohibitive which constitutes a hindrance to their scope especially in the case of smaller research institutions or in areas with limited funds. Such costs can influence the uptake and utilization of new imaging systems.
• Technical Complexity and Integration Issues: The technical complexity of advanced imaging systems and unforeseen challenges of incorporating new components can perhaps determine the success of such systems in the field. This means that both the technology and the operation must be intuitive to the extent that they do not inhibit successful deployment and performance in the field.

How these drivers and challenges interact preclinical in vivo imaging market. The growth is supported by the technology development and demand but market scope is limited by cost, regulatory, exchange, and competition. It will be important to overcome these challenges successfully and at the same time take advantage of drivers to reach the desired outcome in the industry.

List of Preclinical In-Vivo Imaging Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, preclinical in-vivo imaging companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preclinical in-vivo imaging companies profiled in this report include-

• Bruker Corporation
• Siemens
• Trifoil Imaging
• PerkinElmer
• Visualsonics

Preclinical In-Vivo Imaging by Segment

The study includes a forecast for the global preclinical in-vivo imaging market by type, modality, application, distribution channel, and region.

Preclinical In-Vivo Imaging Market by Type [Analysis by Value from 2019 to 2031]:

• Optical Imaging
• Nuclear Imaging
• MRI Contrast Agents
• Ultrasound Contrast Agents
• CT Contrast Agents

Preclinical In-Vivo Imaging Market by Modality [Analysis by Value from 2019 to 2031]:

• Optical Imaging Systems
• Preclinical Nuclear Imaging Systems
• Micro-MRI Systems
• Micro-Ultrasound Systems
• Micro-CT Systems
• Preclinical Photoacoustic Imaging Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems

Preclinical In-Vivo Imaging Market by Application [Analysis by Value from 2019 to 2031]:

• Research & Development
• Drug Discovery

Preclinical In-Vivo Imaging Market by Distribution Channel [Analysis by Value from 2019 to 2031]:

• Pharmaceutical Companies
• Biotechnology Companies
• Research Institutes
• Others

Preclinical In-Vivo Imaging Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Preclinical In-Vivo Imaging Market

With recent improvements in preclinical in vivo imaging, remarkable changes have been noted in the areas of drug development, disease modeling, and biological studies. Such developments are improving the processes of observing and assessing living animals to incorporate the findings into the inventions. Important areas like the US, China, Germany, India, and Japan have been handing help with these improvements in terms of technology and more research.

• United States: Within the U.S., there is a growing trend of applying combined imaging systems such as PET, MRI, and CT, which are favorable because the imaging in animal models is more efficient. Furthermore, the introduction of novel imaging agents and imaging molecules is enhancing the in vivo imaging such that much more detail on the bodily operation and the development of the pathology can be obtained.
• China: China is keeping pace with the development of advanced in vivo imaging systems and seeks high-resolution imaging and monitoring without delay. Focus has been made on developing advanced optical imaging systems and imaging software capable of visualizing cellular and molecular nucleocytoplasmic trafficking in response to defined stimuli with high precision. There is also an inclination towards the use of artificial intelligence (AI) in the analysis and interpretation of images.
• Germany: Germany has added additional new inventions for imaging technologies, for example, high-field MRI and sophisticated fluorescence systems. This has been making it possible for researchers to get even better spatial resolution and visualization of more complex biological processes. Germany is also at the forefront of the quest for new imaging systems combining several imaging modalities in one unit to facilitate studies in vivo Yours.
• India: In India, there is a rising focus on making the preclinical in-vivo imaging systems more advanced as well as more cost effective. The other most recent advancements also include the use of economical imaging systems and the creation of imaging facilities in research centers for drug discovery and disease studies. India is also working on increasing the number of international research organizations that will assist researchers in improving imaging technologies.
• Japan: Japan is taking the initiative in advancing the field of imaging with new inventions like the advanced near-infrared fluorescence imaging system and the high resolution optical imaging. With this, more molecular and cellular targets are being targeted and detected in live animals with the help of these cutting-edge technologies. Japanese researchers are now working on the incorporation of imaging technology and other biological research tools to achieve more profound in vivo findings.

Features of the Global Preclinical In-Vivo Imaging Market

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Preclinical in-vivo imaging market size by various segments, such as by type, modality, application, distribution channel, and region in terms of ($B).

Regional Analysis: Preclinical in-vivo imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, modalities, applications, distribution channels, and regions for the preclinical in-vivo imaging market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the preclinical in-vivo imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the preclinical in-vivo imaging market by type (optical imaging, nuclear imaging, MRI contrast agents, ultrasound contrast agents, and CT contrast agents), modality (optical imaging systems, preclinical nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems), application (research & development and drug discovery), distribution channel (pharmaceutical companies, biotechnology companies, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Preclinical In-Vivo Imaging Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Preclinical In-Vivo Imaging Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Preclinical In-Vivo Imaging Market by Type
  • 3.3.1: Optical Imaging
  • 3.3.2: Nuclear Imaging
  • 3.3.3: MRI Contrast Agents
  • 3.3.4: Ultrasound Contrast Agents
  • 3.3.5: CT Contrast Agents
• 3.4: Global Preclinical In-Vivo Imaging Market by Modality
  • 3.4.1: Optical Imaging Systems
  • 3.4.2: Preclinical Nuclear Imaging Systems
  • 3.4.3: Micro-MRI Systems
  • 3.4.4: Micro-Ultrasound Systems
  • 3.4.5: Micro-CT Systems
  • 3.4.6: Preclinical Photoacoustic Imaging Systems
  • 3.4.7: Preclinical Magnetic Particle Imaging (MPI) Systems
• 3.5: Global Preclinical In-Vivo Imaging Market by Application
  • 3.5.1: Research & Development
  • 3.5.2: Drug Discovery
• 3.6: Global Preclinical In-Vivo Imaging Market by Distribution Channel
  • 3.6.1: Pharmaceutical Companies
  • 3.6.2: Biotechnology Companies
  • 3.6.3: Research Institutes
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Preclinical In-Vivo Imaging Market by Region
• 4.2: North American Preclinical In-Vivo Imaging Market
  • 4.2.1: North American Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.2.2: North American Market by Application: Research & Development and Drug Discovery
• 4.3: European Preclinical In-Vivo Imaging Market
  • 4.3.1: European Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.3.2: European Market by Application: Research & Development and Drug Discovery
• 4.4: APAC Preclinical In-Vivo Imaging Market
  • 4.4.1: APAC Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.4.2: APAC Market by Application: Research & Development and Drug Discovery
• 4.5: ROW Preclinical In-Vivo Imaging Market
  • 4.5.1: ROW Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.5.2: ROW Market by Application: Research & Development and Drug Discovery

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Type
  • 6.1.2: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Modality
  • 6.1.3: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Application
  • 6.1.4: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Region
• 6.2: Emerging Trends in the Global Preclinical In-Vivo Imaging Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Preclinical In-Vivo Imaging Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Preclinical In-Vivo Imaging Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bruker Corporation
• 7.2: Siemens
• 7.3: TriFoil Imaging
• 7.4: PerkinElmer
• 7.5: VisualSonics